Business
Mesoblast (ASX:MSB) share price jumps 19% on FDA update – Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is racing higher on Wednesday after the US FDA granted it a fast track designation for COVID-19 ARDS…
The Mesoblast limited(ASX: MSB) share price has started the day strongly and is racing materially higher.
At the time of writing, the biotechnology company’s shares are up 12% to $4.62. But at one stage they were up as much as 19% to $4.90.
Why is the Mesoblast share price racing higher?
Investors have been buying the company’s shares this morning after the release of a positive announcement relating to its remestemcel-L product.
According to the release, the United States Food and Drug Administration…
-
Noosa News17 hours agoHow Lily Steele-Park took her rapist to court and won
-
General23 hours agoRush to buy homes before rate cuts send prices soaring
-
Business22 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business19 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025